Clinical Trial Update: A Single Site Safety and Tolerability Study of HBOC-201 in Trauma Subjects [Phase 2]

View source ↗

Summary

A Phase 2, single-site safety and tolerability study of HBOC-201 in trauma subjects is being reported; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wounds and Injuries

Drugs mentioned

• HBOC-201

Snippet

Sponsor: Biopure Corporation | Conditions: Wounds and Injuries | Phase 2 | Status: UNKNOWN